RINVOQ — Net revenues
Products & Services · Net revenuesAbbVie RINVOQ — Net revenues increased by 8.7% to $2.37B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 29.4%, from $1.83B to $2.37B. Over 4 years (FY 2021 to FY 2025), RINVOQ — Net revenues shows an upward trend with a 49.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates strong market penetration, successful clinical adoption, or expanded therapeutic indications, while a decrease may signal increased competition, patent cliffs, or loss of market share.
Detailed definition
This metric represents the total gross sales of the specific pharmaceutical product line after accounting for returns, a...
Peer comparison
Comparable to net product sales reported by other major pharmaceutical companies for their flagship or growth-stage therapeutic assets.
abbv_segment_rinvoq_net_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $378.00M | $453.00M | $517.00M | $465.00M | $592.00M | $695.00M | $770.00M | $686.00M | $918.00M | $1.11B | $1.26B | $1.09B | $1.43B | $1.61B | $1.83B | $1.72B | $2.03B | $2.18B | $2.37B |
| QoQ Change | — | +19.8% | +14.1% | -10.1% | +27.3% | +17.4% | +10.8% | -10.9% | +33.8% | +20.9% | +13.1% | -12.9% | +30.8% | +12.9% | +13.6% | -6.3% | +18.0% | +7.7% | +8.7% |
| YoY Change | — | — | — | — | +56.6% | +53.4% | +48.9% | +47.5% | +55.1% | +59.7% | +63.0% | +59.3% | +55.8% | +45.4% | +46.1% | +57.2% | +41.8% | +35.3% | +29.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is AbbVie's rinvoq — net revenues?
- AbbVie (ABBV) reported rinvoq — net revenues of $2.37B in Q4 2025.
- How has AbbVie's rinvoq — net revenues changed year-over-year?
- AbbVie's rinvoq — net revenues increased by 29.4% year-over-year, from $1.83B to $2.37B.
- What is the long-term trend for AbbVie's rinvoq — net revenues?
- Over 4 years (2021 to 2025), AbbVie's rinvoq — net revenues has grown at a 49.8% compound annual growth rate (CAGR), from $1.65B to $8.30B.
- What does rinvoq — net revenues mean?
- The total net sales generated by the specific pharmaceutical product line.